Efficacy of deescalated chemotherapy according to PAM50 subtypes, immune and proliferation genes in triple-negative early breast cancer: Primary translational analysis of the WSG-ADAPT-TN trial

DSpace Repository

Efficacy of deescalated chemotherapy according to PAM50 subtypes, immune and proliferation genes in triple-negative early breast cancer: Primary translational analysis of the WSG-ADAPT-TN trial

Author: Gluz, Oleg; Kolberg-Liedtke, Cornelia; Prat, Aleix; Christgen, Matthias; Gebauer, Daniel; Kates, Ronald; Pare, Laia; Grischke, Eva-Maria; Forstbauer, Helmut; Braun, Michael; Warm, Mathias; Hackmann, John; Uleer, Christoph; Aktas, Bahriye; Schumacher, Claudia; Kuemmel, Sherko; Wuerstlein, Rachel; Pelz, Enrico; Nitz, Ulrike; Kreipe, Hans Heinrich; Harbeck, Nadia
Tübinger Autor(en):
Grischke, Eva-Maria
Published in: International Journal of Cancer (2020), Bd. 146, H. 1, S. 262-271
Verlagsangabe: Wiley
Language: English
Full text: http://dx.doi.org/10.1002/ijc.32488
ISSN: 1097-0215
DDC Classifikation: 610 - Medicine and health
Dokumentart: Article
Show full item record

This item appears in the following Collection(s)